Global Pediatric Drugs and Vaccines Market Research Report 2023

Global Pediatric Drugs and Vaccines Market Research Report 2023

Table of Contents
1 Pediatric Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Pediatric Drugs and Vaccines Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Pediatric Drugs and Vaccines Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Market Value by Application: (2023-2029)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Global Pediatric Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Drugs and Vaccines Revenue 2018-2029
1.4.2 Global Pediatric Drugs and Vaccines Sales 2018-2029
1.4.3 Global Pediatric Drugs and Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pediatric Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pediatric Drugs and Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Pediatric Drugs and Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pediatric Drugs and Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Drugs and Vaccines, Product Type & Application
2.7 Pediatric Drugs and Vaccines Market Competitive Situation and Trends
2.7.1 Pediatric Drugs and Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pediatric Drugs and Vaccines Players Market Share by Revenue
2.7.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pediatric Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pediatric Drugs and Vaccines Global Pediatric Drugs and Vaccines Sales by Region: 2018-2029
3.2.1 Global Pediatric Drugs and Vaccines Sales by Region: 2018-2023
3.2.2 Global Pediatric Drugs and Vaccines Sales by Region: 2024-2029
3.3 Global Pediatric Drugs and Vaccines Global Pediatric Drugs and Vaccines Revenue by Region: 2018-2029
3.3.1 Global Pediatric Drugs and Vaccines Revenue by Region: 2018-2023
3.3.2 Global Pediatric Drugs and Vaccines Revenue by Region: 2024-2029
3.4 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.4.1 North America Pediatric Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pediatric Drugs and Vaccines Sales by Country (2018-2029)
3.4.3 North America Pediatric Drugs and Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.5.1 Europe Pediatric Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pediatric Drugs and Vaccines Sales by Country (2018-2029)
3.5.3 Europe Pediatric Drugs and Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Pediatric Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pediatric Drugs and Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific Pediatric Drugs and Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Latin America Pediatric Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pediatric Drugs and Vaccines Sales by Country (2018-2029)
3.7.3 Latin America Pediatric Drugs and Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pediatric Drugs and Vaccines Sales by Type (2018-2029)
4.1.1 Global Pediatric Drugs and Vaccines Sales by Type (2018-2023)
4.1.2 Global Pediatric Drugs and Vaccines Sales by Type (2024-2029)
4.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Pediatric Drugs and Vaccines Revenue by Type (2018-2029)
4.2.1 Global Pediatric Drugs and Vaccines Revenue by Type (2018-2023)
4.2.2 Global Pediatric Drugs and Vaccines Revenue by Type (2024-2029)
4.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Pediatric Drugs and Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pediatric Drugs and Vaccines Sales by Application (2018-2029)
5.1.1 Global Pediatric Drugs and Vaccines Sales by Application (2018-2023)
5.1.2 Global Pediatric Drugs and Vaccines Sales by Application (2024-2029)
5.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Pediatric Drugs and Vaccines Revenue by Application (2018-2029)
5.2.1 Global Pediatric Drugs and Vaccines Revenue by Application (2018-2023)
5.2.2 Global Pediatric Drugs and Vaccines Revenue by Application (2024-2029)
5.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Pediatric Drugs and Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co., Inc. (USA)
6.1.1 Merck & Co., Inc. (USA) Corporation Information
6.1.2 Merck & Co., Inc. (USA) Description and Business Overview
6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.1.5 Merck & Co., Inc. (USA) Recent Developments/Updates
6.2 Abbott Laboratories (USA)
6.2.1 Abbott Laboratories (USA) Corporation Information
6.2.2 Abbott Laboratories (USA) Description and Business Overview
6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolio
6.2.5 Abbott Laboratories (USA) Recent Developments/Updates
6.3 Amgen, Inc. (USA)
6.3.1 Amgen, Inc. (USA) Corporation Information
6.3.2 Amgen, Inc. (USA) Description and Business Overview
6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.3.5 Amgen, Inc. (USA) Recent Developments/Updates
6.4 Eli Lilly and Company (USA)
6.4.1 Eli Lilly and Company (USA) Corporation Information
6.4.2 Eli Lilly and Company (USA) Description and Business Overview
6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.4.5 Eli Lilly and Company (USA) Recent Developments/Updates
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
6.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
6.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
6.6 Genentech, Inc. (USA)
6.6.1 Genentech, Inc. (USA) Corporation Information
6.6.2 Genentech, Inc. (USA) Description and Business Overview
6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.6.5 Genentech, Inc. (USA) Recent Developments/Updates
6.7 GlaxoSmithKline plc. (UK)
6.6.1 GlaxoSmithKline plc. (UK) Corporation Information
6.6.2 GlaxoSmithKline plc. (UK) Description and Business Overview
6.6.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.7.5 GlaxoSmithKline plc. (UK) Recent Developments/Updates
6.8 Janssen Biologics B.V. (USA)
6.8.1 Janssen Biologics B.V. (USA) Corporation Information
6.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.8.5 Janssen Biologics B.V. (USA) Recent Developments/Updates
6.9 Actelion Pharmaceuticals
6.9.1 Actelion Pharmaceuticals Corporation Information
6.9.2 Actelion Pharmaceuticals Description and Business Overview
6.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolio
6.9.5 Actelion Pharmaceuticals Recent Developments/Updates
6.10 AstraZeneca Plc. (UK)
6.10.1 AstraZeneca Plc. (UK) Corporation Information
6.10.2 AstraZeneca Plc. (UK) Description and Business Overview
6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolio
6.10.5 AstraZeneca Plc. (UK) Recent Developments/Updates
6.11 Boehringer Ingelheim GmbH (Germany)
6.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
6.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Description and Business Overview
6.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolio
6.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
6.12 Bristol-Myers Squibb Company (USA)
6.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
6.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolio
6.12.5 Bristol-Myers Squibb Company (USA) Recent Developments/Updates
6.13 Allergan, Inc. (USA)
6.13.1 Allergan, Inc. (USA) Corporation Information
6.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.13.5 Allergan, Inc. (USA) Recent Developments/Updates
6.14 Novartis AG (Switzerland)
6.14.1 Novartis AG (Switzerland) Corporation Information
6.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Description and Business Overview
6.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolio
6.14.5 Novartis AG (Switzerland) Recent Developments/Updates
6.15 Novo Nordisk A/S (Denmark)
6.15.1 Novo Nordisk A/S (Denmark) Corporation Information
6.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Description and Business Overview
6.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolio
6.15.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates
6.16 Pfizer, Inc. (USA)
6.16.1 Pfizer, Inc. (USA) Corporation Information
6.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.16.5 Pfizer, Inc. (USA) Recent Developments/Updates
6.17 Sanofi S.A (France)
6.17.1 Sanofi S.A (France) Corporation Information
6.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Description and Business Overview
6.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolio
6.17.5 Sanofi S.A (France) Recent Developments/Updates
6.18 Shionogi Inc. (USA)
6.18.1 Shionogi Inc. (USA) Corporation Information
6.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Description and Business Overview
6.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolio
6.18.5 Shionogi Inc. (USA) Recent Developments/Updates
6.19 Takeda
6.19.1 Takeda Corporation Information
6.19.2 Takeda Pediatric Drugs and Vaccines Description and Business Overview
6.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Takeda Pediatric Drugs and Vaccines Product Portfolio
6.19.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Drugs and Vaccines Industry Chain Analysis
7.2 Pediatric Drugs and Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Drugs and Vaccines Production Mode & Process
7.4 Pediatric Drugs and Vaccines Sales and Marketing
7.4.1 Pediatric Drugs and Vaccines Sales Channels
7.4.2 Pediatric Drugs and Vaccines Distributors
7.5 Pediatric Drugs and Vaccines Customers
8 Pediatric Drugs and Vaccines Market Dynamics
8.1 Pediatric Drugs and Vaccines Industry Trends
8.2 Pediatric Drugs and Vaccines Market Drivers
8.3 Pediatric Drugs and Vaccines Market Challenges
8.4 Pediatric Drugs and Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Pediatric Drugs and Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Pediatric Drugs and Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pediatric Drugs and Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Pediatric Drugs and Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Pediatric Drugs and Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Pediatric Drugs and Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pediatric Drugs and Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Pediatric Drugs and Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Pediatric Drugs and Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Pediatric Drugs and Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global Pediatric Drugs and Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Pediatric Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America Pediatric Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Pediatric Drugs and Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Pediatric Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Pediatric Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Pediatric Drugs and Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Pediatric Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Pediatric Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Pediatric Drugs and Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pediatric Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Pediatric Drugs and Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Pediatric Drugs and Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Type (2024-2029)
Table 60. Global Pediatric Drugs and Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Pediatric Drugs and Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Pediatric Drugs and Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global Pediatric Drugs and Vaccines Price (USD/Unit) by Application (2024-2029)
Table 70. Merck & Co., Inc. (USA) Corporation Information
Table 71. Merck & Co., Inc. (USA) Description and Business Overview
Table 72. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product
Table 74. Merck & Co., Inc. (USA) Recent Developments/Updates
Table 75. Abbott Laboratories (USA) Corporation Information
Table 76. Abbott Laboratories (USA) Description and Business Overview
Table 77. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product
Table 79. Abbott Laboratories (USA) Recent Developments/Updates
Table 80. Amgen, Inc. (USA) Corporation Information
Table 81. Amgen, Inc. (USA) Description and Business Overview
Table 82. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 84. Amgen, Inc. (USA) Recent Developments/Updates
Table 85. Eli Lilly and Company (USA) Corporation Information
Table 86. Eli Lilly and Company (USA) Description and Business Overview
Table 87. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product
Table 89. Eli Lilly and Company (USA) Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 91. F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product
Table 94. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments/Updates
Table 95. Genentech, Inc. (USA) Corporation Information
Table 96. Genentech, Inc. (USA) Description and Business Overview
Table 97. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 99. Genentech, Inc. (USA) Recent Developments/Updates
Table 100. GlaxoSmithKline plc. (UK) Corporation Information
Table 101. GlaxoSmithKline plc. (UK) Description and Business Overview
Table 102. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product
Table 104. GlaxoSmithKline plc. (UK) Recent Developments/Updates
Table 105. Janssen Biologics B.V. (USA) Corporation Information
Table 106. Janssen Biologics B.V. (USA) Description and Business Overview
Table 107. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product
Table 109. Janssen Biologics B.V. (USA) Recent Developments/Updates
Table 110. Actelion Pharmaceuticals Corporation Information
Table 111. Actelion Pharmaceuticals Description and Business Overview
Table 112. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product
Table 114. Actelion Pharmaceuticals Recent Developments/Updates
Table 115. AstraZeneca Plc. (UK) Corporation Information
Table 116. AstraZeneca Plc. (UK) Description and Business Overview
Table 117. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product
Table 119. AstraZeneca Plc. (UK) Recent Developments/Updates
Table 120. Boehringer Ingelheim GmbH (Germany) Corporation Information
Table 121. Boehringer Ingelheim GmbH (Germany) Description and Business Overview
Table 122. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product
Table 124. Boehringer Ingelheim GmbH (Germany) Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company (USA) Corporation Information
Table 126. Bristol-Myers Squibb Company (USA) Description and Business Overview
Table 127. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product
Table 129. Bristol-Myers Squibb Company (USA) Recent Developments/Updates
Table 130. Allergan, Inc. (USA) Corporation Information
Table 131. Allergan, Inc. (USA) Description and Business Overview
Table 132. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 134. Allergan, Inc. (USA) Recent Developments/Updates
Table 135. Novartis AG (Switzerland) Corporation Information
Table 136. Novartis AG (Switzerland) Description and Business Overview
Table 137. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product
Table 139. Novartis AG (Switzerland) Recent Developments/Updates
Table 140. Novo Nordisk A/S (Denmark) Corporation Information
Table 141. Novo Nordisk A/S (Denmark) Description and Business Overview
Table 142. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product
Table 144. Novo Nordisk A/S (Denmark) Recent Developments/Updates
Table 145. Pfizer, Inc. (USA) Corporation Information
Table 146. Pfizer, Inc. (USA) Description and Business Overview
Table 147. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product
Table 149. Pfizer, Inc. (USA) Recent Developments/Updates
Table 150. Sanofi S.A (France) Corporation Information
Table 151. Sanofi S.A (France) Description and Business Overview
Table 152. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Sanofi S.A (France) Pediatric Drugs and Vaccines Product
Table 154. Sanofi S.A (France) Recent Developments/Updates
Table 155. Shionogi Inc. (USA) Corporation Information
Table 156. Shionogi Inc. (USA) Description and Business Overview
Table 157. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product
Table 159. Shionogi Inc. (USA) Recent Developments/Updates
Table 160. Takeda Corporation Information
Table 161. Takeda Description and Business Overview
Table 162. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 163. Takeda Pediatric Drugs and Vaccines Product
Table 164. Takeda Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Pediatric Drugs and Vaccines Distributors List
Table 168. Pediatric Drugs and Vaccines Customers List
Table 169. Pediatric Drugs and Vaccines Market Trends
Table 170. Pediatric Drugs and Vaccines Market Drivers
Table 171. Pediatric Drugs and Vaccines Market Challenges
Table 172. Pediatric Drugs and Vaccines Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Drugs and Vaccines
Figure 2. Global Pediatric Drugs and Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Pediatric Drugs and Vaccines Market Share by Type in 2022 & 2029
Figure 4. Diphtheria Product Picture
Figure 5. Influenza Pro

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs